Bioxytran
Newton, US
Biotech
Founders & leadership
AH
Alan H HobermanDirector
SO
Soderquist OlaExecutive Officer
DH
Dale H ConawayDirector
DP
David PlattExecutive Officer, Director
HJ
Henry J. EsberDirector
AN
Anders N. UtterDirector
Reported raises · per SEC filings
Form D private placements$130KraisedMar 2023 · 3 investors · Biotechnology
Rule 506(b)$600KraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)$1.5MraisedJan 2022 · 34 investors · Biotechnology
Rule 506(b)$3.3MraisedJul 2021 · 9 investors · Biotechnology
Rule 506(b)$332.3KraisedNov 2019 · 1 investors · Biotechnology
Rule 506(b)$250KraisedNov 2018 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.